These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 23379492

  • 1. Survey of the effects of a column for adsorption of β2-microglobulin in patients with dialysis-related amyloidosis in Japan.
    Gejyo F, Amano I, Ando T, Ishida M, Obayashi S, Ogawa H, Ono T, Kanno Y, Kitaoka T, Kukita K, Kurihara S, Sato M, Shin J, Suzuki M, Takahashi S, Taguma Y, Takemoto Y, Nakazawa R, Nakanishi T, Nakamura H, Hara S, Hiramatsu M, Furuya R, Masakane I, Tsuchida K, Motomiya Y, Morita H, Yamagata K, Yoshiya K, Yamakawa T, Society of β2-Microglobulin Adsorption Therapy.
    Ther Apher Dial; 2013 Feb; 17(1):40-7. PubMed ID: 23379492
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term efficacy and safety of the small-sized β2-microglobulin adsorption column for dialysis-related amyloidosis.
    Yamamoto Y, Hirawa N, Yamaguchi S, Ogawa N, Takeda H, Shibuya K, Kawahara K, Kojima H, Dobashi Y, Fujita M, Azusima K, Miyazaki N, Kobayashi M, Kobayashi C, Fujiwara A, Yuto J, Saka S, Yatsu K, Toya Y, Yasuda G, Ohnishi T, Umemura S.
    Ther Apher Dial; 2011 Oct; 15(5):466-74. PubMed ID: 21974700
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Beta2-microglobulin-selective adsorbent column (Lixelle) for the treatment of dialysis-related amyloidosis.
    Suzuki K, Shimazaki M, Kutsuki H.
    Ther Apher Dial; 2003 Feb; 7(1):104-7. PubMed ID: 12921124
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Performance of the newer type (Lixelle Type S-15) on direct hemoperfusion beta-2-microglobulin adsorption column for dialysis-related amyloidosis.
    Hiyama E, Hyodo T, Kondo M, Otsuka K, Honma T, Taira T, Yoshida K, Uchida T, Endo T, Sakai T, Baba S, Hidai H.
    Nephron; 2002 Oct; 92(2):501-2. PubMed ID: 12218344
    [No Abstract] [Full Text] [Related]

  • 8. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J.
    Przegl Lek; 2006 Oct; 63(7):567-72. PubMed ID: 17203811
    [Abstract] [Full Text] [Related]

  • 9. New adsorption column (Lixelle) to eliminate beta2-microglobulin for direct hemoperfusion.
    Furuyoshi S, Nakatani M, Taman J, Kutsuki H, Takata S, Tani N.
    Ther Apher; 1998 Feb; 2(1):13-7. PubMed ID: 10227783
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of β(2)-microglobulin adsorption column in treating dialysis-related amyloidosis: a multicenter study.
    Kuragano T, Inoue T, Yoh K, Shin J, Fujita Y, Yoshiya K, Kim JI, Sakai R, Sekita K, Goto T, Fukagawa M, Nakanishi T.
    Blood Purif; 2011 Feb; 32(4):317-22. PubMed ID: 21934303
    [Abstract] [Full Text] [Related]

  • 11. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].
    Higuchi N, Maruyama H.
    Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036
    [Abstract] [Full Text] [Related]

  • 12. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F, Homma N, Arakawa M.
    Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
    [Abstract] [Full Text] [Related]

  • 13. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A, Gejyo F.
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Direct hemoperfusion with a beta2-microglobulin-selective adsorbent column eliminates inflammatory cytokines and improves pulmonary oxygenation.
    Kono K, Toda S, Hora K, Kiyosawa K.
    Ther Apher Dial; 2009 Feb; 13(1):27-33. PubMed ID: 19379167
    [Abstract] [Full Text] [Related]

  • 16. Long-term clinical evaluation of an adsorbent column (BM-01) of direct hemoperfusion type for beta 2-microglobulin on the treatment of dialysis-related amyloidosis.
    Gejyo F, Teramura T, Ei I, Arakawa M, Nakazawa R, Azuma N, Suzuki M, Furuyoshi S, Nankou T, Takata S.
    Artif Organs; 1995 Dec; 19(12):1222-6. PubMed ID: 8967878
    [Abstract] [Full Text] [Related]

  • 17. A new treatment for dialysis-related amyloidosis with beta 2-microglobulin adsorbent column.
    Nakazawa R, Azuma N, Suzuki M, Nakatani M, Nankou T, Furuyoshi S, Yasuda A, Takata S, Tani N, Kobayashi F.
    Int J Artif Organs; 1993 Dec; 16(12):823-9. PubMed ID: 8175198
    [Abstract] [Full Text] [Related]

  • 18. Blood purification for critical illness: cytokines adsorption therapy.
    Tsuchida K, Yoshimura R, Nakatani T, Takemoto Y.
    Ther Apher Dial; 2006 Feb; 10(1):25-31. PubMed ID: 16556133
    [Abstract] [Full Text] [Related]

  • 19. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
    Miyata T.
    Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
    [Abstract] [Full Text] [Related]

  • 20. [Contribution of Japanese researchers to progress in studies on nephrology in the past 100 years: Beta2-microglobulin as an etiological factor of amyloidosis in patients undergoing hemodialysis].
    Gejo F.
    Nihon Naika Gakkai Zasshi; 2002 May 10; 91(5):1434-6. PubMed ID: 12082730
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.